A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma.
Hendrickson, Andrea E Wahner
A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma. [electronic resource] - Gynecologic oncology Feb 2012 - 210-5 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
1095-6859
10.1016/j.ygyno.2011.10.002 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Benzoquinones--administration & dosage
Biomarkers, Tumor--metabolism
Carcinoma, Ovarian Epithelial
Cell Line, Tumor
Cohort Studies
Deoxycytidine--administration & dosage
Female
HSP70 Heat-Shock Proteins--metabolism
HSP90 Heat-Shock Proteins--metabolism
Humans
Lactams, Macrocyclic--administration & dosage
Middle Aged
Neoplasms, Glandular and Epithelial--drug therapy
Ovarian Neoplasms--drug therapy
Peritoneal Neoplasms--drug therapy
Survival Rate
Gemcitabine
A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma. [electronic resource] - Gynecologic oncology Feb 2012 - 210-5 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
1095-6859
10.1016/j.ygyno.2011.10.002 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Benzoquinones--administration & dosage
Biomarkers, Tumor--metabolism
Carcinoma, Ovarian Epithelial
Cell Line, Tumor
Cohort Studies
Deoxycytidine--administration & dosage
Female
HSP70 Heat-Shock Proteins--metabolism
HSP90 Heat-Shock Proteins--metabolism
Humans
Lactams, Macrocyclic--administration & dosage
Middle Aged
Neoplasms, Glandular and Epithelial--drug therapy
Ovarian Neoplasms--drug therapy
Peritoneal Neoplasms--drug therapy
Survival Rate
Gemcitabine